CO7170168A2 - Agente líquido tópico para el tratamiento de la dermatofitosis - Google Patents
Agente líquido tópico para el tratamiento de la dermatofitosisInfo
- Publication number
- CO7170168A2 CO7170168A2 CO14281705A CO14281705A CO7170168A2 CO 7170168 A2 CO7170168 A2 CO 7170168A2 CO 14281705 A CO14281705 A CO 14281705A CO 14281705 A CO14281705 A CO 14281705A CO 7170168 A2 CO7170168 A2 CO 7170168A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- hydrogen atom
- halogen
- liquid agent
- topical liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
De acuerdo con la presente invención, se puedeproporcionar un agente líquido tópico que tenga actividadantifúngica contra dermatofitos y también altapermeabilidad en uñas.El agente líquido tópico para las uñas y/o la pielpara la prevención o el tratamiento de dermatofitosiscomprende un agente formador de película y un compuestorepresentado por la fórmula(I)en donde R1 representa un átomo de hidrógeno, alquilo C16 otrifluorometilo, R2 representa un átomo de hidrógeno,alquilo C16, halógeno, COO(alquilo C16) o (CH2)13COOR,donde R representa un átomo de hidrógeno o alquilo C16, R3representa un átomo de hidrógeno, alquilo C16, amino,trifluorometilo u OR, donde R representa un átomo dehidrógeno o alquilo C16, R4 representa un grupo hidroxilo,R5 representa un átomo de hidrógeno, alquilo C16, un grupohidroxilo o halógeno, R6 representa un átomo de hidrógeno,alquilo C16, trifluorometilo, halógeno, amino, NRaRb,nitro, hidroxialquilo C16, CONRaRb, COO(alquilo C16), COOH, (CH2)13COOR u ORa donde R representa un átomo dehidrógeno o alquilo C16, Ra y Rb pueden ser iguales odiferentes entre sí y cada uno representa un átomo dehidrógeno, alquilo C16 o acilo C16, R7 representa un átomode hidrógeno, alquilo C16, OR, donde R representa un átomode hidrógeno o alquilo C16 o halógeno, R8 representa unátomo de hidrógeno, alquilo C16, un grupo hidroxilo, aminoo nitro,o una de sus sales.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012069306 | 2012-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO7170168A2 true CO7170168A2 (es) | 2015-01-28 |
Family
ID=49995097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO14281705A CO7170168A2 (es) | 2012-07-30 | 2014-12-23 | Agente líquido tópico para el tratamiento de la dermatofitosis |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20140030209A1 (es) |
| EP (1) | EP2889031A4 (es) |
| JP (1) | JP6132842B2 (es) |
| KR (1) | KR20150038314A (es) |
| CN (1) | CN104661661A (es) |
| AR (1) | AR092358A1 (es) |
| AU (1) | AU2013297602A1 (es) |
| BR (1) | BR112015001235A2 (es) |
| CA (1) | CA2879846A1 (es) |
| CL (1) | CL2015000218A1 (es) |
| CO (1) | CO7170168A2 (es) |
| HK (1) | HK1210718A1 (es) |
| IL (1) | IL236993A0 (es) |
| MX (1) | MX2015001416A (es) |
| PH (1) | PH12015500224A1 (es) |
| RU (1) | RU2015106906A (es) |
| SG (1) | SG11201500637QA (es) |
| TW (1) | TW201410239A (es) |
| WO (1) | WO2014021282A1 (es) |
| ZA (1) | ZA201500809B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201410273A (zh) | 2012-07-30 | 2014-03-16 | Meiji Seika Pharma Co Ltd | 抗白癬菌症貼附劑 |
| CA2957880A1 (en) | 2014-08-13 | 2016-02-18 | Meiji Seika Pharma Co., Ltd. | Crystalline anti-trichophyton agents and preparation process thereof |
| ES2766424T3 (es) * | 2015-03-19 | 2020-06-12 | Daiichi Sankyo Co Ltd | Preparación sólida que contienen agente oxidante |
| ES2821733T3 (es) | 2015-03-19 | 2021-04-27 | Daiichi Sankyo Co Ltd | Preparación sólida que contiene colorante |
| CN107311838A (zh) * | 2017-07-13 | 2017-11-03 | 柳州丰康泰科技有限公司 | 一种新的合成环丙基溴的方法 |
| WO2019150485A1 (ja) * | 2018-01-31 | 2019-08-08 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 爪白癬の予防又は治療用外用液剤 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3628892A1 (de) * | 1986-08-26 | 1988-03-10 | Bayer Ag | Substituierte 1-aryl-3-tert.-butyl-pyrazole |
| ES2015648A6 (es) | 1989-05-05 | 1990-09-01 | Consejo Superior Investigacion | Procedeimiento de sintesis de mono y bis (3-r3-4-r4-5-r5-pirazol-1-il)1,4-dihidroxibencenos. |
| US5391367A (en) * | 1993-07-28 | 1995-02-21 | Pfizer Inc. | Antifungal nail solution |
| DE4414897A1 (de) | 1994-04-28 | 1995-11-02 | Hoechst Ag | Aromatische Diazoniumsalze und deren Verwendung in strahlungsempfindlichen Gemischen |
| JP3729884B2 (ja) | 1995-01-05 | 2005-12-21 | 関東電化工業株式会社 | フルオロフェノール類の製造方法 |
| JPH1160528A (ja) | 1997-08-12 | 1999-03-02 | Ube Ind Ltd | ４−クロロ−３−トリフルオロメチルフェノールの製法 |
| EP1144383A1 (en) * | 1999-01-14 | 2001-10-17 | Merck Frosst Canada & Co. | Synthesis of 4-[(5-substituted or unsubstituted phenyl)-3-substituted-1h-pyrazol-1-yl]benzenesulfonamides |
| EP1175393B1 (en) | 2000-03-03 | 2004-06-09 | Sumitomo Chemical Company Limited | Process for the preparation of phenylhydrazines |
| EP1408950B1 (en) | 2001-07-11 | 2007-04-25 | Boehringer Ingelheim Pharmaceuticals Inc. | Methods of treating cytokine mediated diseases |
| AU2003271117A1 (en) * | 2002-10-09 | 2004-05-04 | Ssp Co., Ltd. | Novel pyrazole compounds having antifungal activity |
| KR100509603B1 (ko) * | 2002-12-28 | 2005-08-22 | 삼성에스디아이 주식회사 | 적색 발광 화합물 및 이를 채용한 유기 전계 발광 소자 |
| KR101093990B1 (ko) * | 2003-03-21 | 2011-12-16 | 넥스메드 홀딩스 인코포레이티드 | 항진균성 네일 코트 및 사용 방법 |
| US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
| EP1981860B1 (en) | 2006-01-19 | 2011-05-25 | Matrix Laboratories Ltd | Conversion of aromatic diazonium salt to aryl hydrazine |
| WO2008024978A2 (en) * | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Tetrahydroindolone and tetrahydroindazolone derivatives |
| CN101011560A (zh) * | 2007-02-13 | 2007-08-08 | 贵州神奇集团控股有限公司 | 治疗脚手癣、灰指甲的中西复方制剂及其制备方法和质控方法 |
| CN103339112B (zh) * | 2011-01-30 | 2015-08-12 | 明治制果药业株式会社 | 外用抗真菌剂 |
-
2013
- 2013-07-30 US US13/954,804 patent/US20140030209A1/en not_active Abandoned
- 2013-07-30 BR BR112015001235A patent/BR112015001235A2/pt not_active IP Right Cessation
- 2013-07-30 WO PCT/JP2013/070525 patent/WO2014021282A1/ja active Application Filing
- 2013-07-30 AU AU2013297602A patent/AU2013297602A1/en not_active Abandoned
- 2013-07-30 CA CA2879846A patent/CA2879846A1/en not_active Abandoned
- 2013-07-30 JP JP2014528154A patent/JP6132842B2/ja not_active Expired - Fee Related
- 2013-07-30 KR KR20157004795A patent/KR20150038314A/ko not_active Application Discontinuation
- 2013-07-30 AR ARP130102697A patent/AR092358A1/es unknown
- 2013-07-30 TW TW102127227A patent/TW201410239A/zh unknown
- 2013-07-30 MX MX2015001416A patent/MX2015001416A/es unknown
- 2013-07-30 RU RU2015106906A patent/RU2015106906A/ru not_active Application Discontinuation
- 2013-07-30 EP EP13825029.5A patent/EP2889031A4/en not_active Withdrawn
- 2013-07-30 SG SG11201500637QA patent/SG11201500637QA/en unknown
- 2013-07-30 CN CN201380040338.3A patent/CN104661661A/zh active Pending
-
2014
- 2014-12-23 CO CO14281705A patent/CO7170168A2/es unknown
-
2015
- 2015-01-28 CL CL2015000218A patent/CL2015000218A1/es unknown
- 2015-01-29 IL IL236993A patent/IL236993A0/en unknown
- 2015-01-30 PH PH12015500224A patent/PH12015500224A1/en unknown
- 2015-02-04 ZA ZA2015/00809A patent/ZA201500809B/en unknown
- 2015-11-26 HK HK15111656.5A patent/HK1210718A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201410239A (zh) | 2014-03-16 |
| KR20150038314A (ko) | 2015-04-08 |
| BR112015001235A2 (pt) | 2017-07-04 |
| CL2015000218A1 (es) | 2015-05-22 |
| JPWO2014021282A1 (ja) | 2016-07-21 |
| AU2013297602A1 (en) | 2015-02-19 |
| RU2015106906A (ru) | 2016-09-20 |
| HK1210718A1 (en) | 2016-05-06 |
| EP2889031A1 (en) | 2015-07-01 |
| SG11201500637QA (en) | 2015-03-30 |
| MX2015001416A (es) | 2015-05-08 |
| ZA201500809B (en) | 2016-04-28 |
| US20140030209A1 (en) | 2014-01-30 |
| JP6132842B2 (ja) | 2017-05-24 |
| AR092358A1 (es) | 2015-04-15 |
| EP2889031A4 (en) | 2016-01-06 |
| CA2879846A1 (en) | 2014-02-06 |
| PH12015500224A1 (en) | 2015-04-06 |
| WO2014021282A1 (ja) | 2014-02-06 |
| CN104661661A (zh) | 2015-05-27 |
| IL236993A0 (en) | 2015-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO7170168A2 (es) | Agente líquido tópico para el tratamiento de la dermatofitosis | |
| CO2020001879A2 (es) | Compuesto heterocíclico y su uso | |
| UY33547A (es) | COMPUESTOS QUÍMICOS Bcl-2 y Bcl-XL | |
| DOP2019000193A (es) | Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende | |
| CO6680699A2 (es) | Derivados de amina para el control de plagas | |
| BR112014025564A2 (pt) | composto heterocíclico contendo nitrogênio ou sal do mesmo | |
| BR112014028042A2 (pt) | inibidores de nampt | |
| AR094997A1 (es) | Sales y formas sólidas de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona y composiciones que las comprenden y sus usos | |
| PE20150289A1 (es) | Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos | |
| UY36263A (es) | Compuestos de tiazin-2-amina fusionados con ciclopropilo como inhibidores de beta-secretasa y métodos de uso | |
| ECSP17069696A (es) | Compuestos novedosos | |
| BR112015008849A2 (pt) | composições estáveis contendo perácido | |
| PE20160801A1 (es) | Derivados de heterobicicloaril como inhibidores rorc2 y metodos de uso de los mismos | |
| BR112017011913A2 (pt) | agente de tratamento para deformação de cabelos | |
| AR084948A1 (es) | Agente antifungico topico | |
| PE20190979A1 (es) | Compuestos de heteroarilcarboxamida como inhibidores de ripk2 | |
| EA201491276A1 (ru) | Новые производные бензилсульфонамида, подходящие для применения в качестве ингибиторов mogat-2 | |
| CL2017000040A1 (es) | Inhibidores de aldosterona sintasa. | |
| BR112016021171B8 (pt) | processo para fabricação de composto oticamente ativo | |
| BR112018008951A2 (pt) | composto de aminoácido, complexo, mistura, fertilizante, e, agente regulador de crescimento de plantas. | |
| EA202090470A1 (ru) | Композиция для личного ухода | |
| UY35685A (es) | Compuestos de dióxido de amino tiazina bicíclicos puenteados como inhibidores de beta-secretasa y sus métodos de uso | |
| EA201692270A1 (ru) | Производные нафтиридиндиона | |
| TN2018000075A1 (fr) | Extrait de gardenia dans la coloration de la peau | |
| BR112017011912A2 (pt) | agente para o tratamento contra deformação do cabelo |